A malignancy risk prediction model for Bethesda category III thyroid nodules based on serological indicators, C-TIRADS, and BRAF V600E testing

Wei Yang, Chun Jin Xiong, Shuang Shuang Dong, Bin Sheng · 2026

Read A malignancy risk prediction model for Bethesda category III thyroid nodules based on serological indicators, C-TIRADS, and BRAF V600E testing by Wei Yang, Chun Jin Xiong, Shuang Shuang Dong, Bin Sheng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13645610.txt.

Description

Wei Yang and three colleagues build a risk model for thyroid nodules whose needle test results land in an uncertain middle class, Bethesda category III. Their records cover ninety-three patients treated at a Jiangsu hospital between July 2020 and June 2025, all of whom later had surgery. The model combines two antibody blood tests, an ultrasound grading system, and a gene mutation test. A chart called a nomogram turns the model into individual risk estimates.

Most nodules in this surgical group proved cancerous, which reflects the high-risk setting. The gene test alone was the strongest single predictor, yet the combined model scored clearly better than any one part. The authors say the combined approach can help doctors sort patients before surgery and choose who needs an operation most. They also note the model was checked only within the same patient group, so wider testing is still needed.

Catalog record

CREATORWei Yang, Chun Jin Xiong, Shuang Shuang Dong, Bin Sheng
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13645610

Browse the full library · About the Tower of Babel